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Embryonic tissueUCP4 is a member of the mitochondrial uncoupling protein subfamily and one of the three UCPs (UCP2, UCP4,
UCP5), associated with the nervous system. Its putative functions include thermogenesis, attenuation of
reactive oxidative species (ROS), regulation of mitochondrial calcium concentration and involvement in cell
differentiation and apoptosis. Here we investigate UCP4's subcellular, cellular and tissue distribution, using
an antibody designed specially for this study, and discuss the ﬁndings in terms of the protein's possible
functions. Western blot and immunohistochemistry data conﬁrmed that UCP4 is expressed predominantly in
the central nervous system (CNS), as previously shown at mRNA level. No protein was found in heart, spleen,
stomach, intestine, lung, thymus, muscles, adrenal gland, testis and liver. The reports revealing UCP4 mRNA
in kidney and white adipose tissue were not conﬁrmed at protein level. The amount of UCP4 varies in the
mitochondria of different brain regions, with the highest protein content found in cortex. We show that
UCP4 is present in fetal murine brain tissue as early as embryonic days 12–14 (E12–E14), which coincides
with the beginning of neuronal differentiation. The UCP4 content in mitochondria decreases as the age of
mice increases. UCP4 preferential expression in neurons and its developmental expression pattern under
physiological conditions may indicate a speciﬁc protein function, e.g. in neuronal cell differentiation.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Uncoupling protein 4 (UCP4) belongs to the large family of
mitochondrial anion carriers. Although it was ﬁrst described in 1999
[1], its function and distribution at protein level are still unknown.
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ll rights reserved.mediated by brown adipose tissue (BAT) [2,3], UCP4 is thought to
regulate proton leak [1,4,5] because of its homology to UCP1 (approx.
30%) and the reduction of mitochondrial membrane potential after
UCP4 ectopic non-neuronal expression [1,6,7]. However, its ability to
transport protons has not been directly demonstrated. Even if UCP4-
mediated proton transport is conﬁrmed, this would not necessarily
imply a deﬁnite physiological role, as is the case for several members
of the mitochondrial anion carrier family (e.g. ANT [8], oxoglutarate
carrier [9]), which can perform as proton transporters when
expressed in artiﬁcial systems. Although phylogenetic analysis
shows that UCP4 and UCP5 are more closely related to oxoglutarate
and dicarboxylate carriers than to UCP1/UCP2/UCP3 [10], the
existence of unique uncoupling protein signature sequences, which
is lacking e.g. in the oxoglutarate carrier [11], may justify their
assignment to a distinct cluster of the mitochondrial anion carrier
family, the UCP subfamily.
mRNA of UCP4 and two other uncoupling proteins, UCP2 and UCP5
(BMCP1), has been found in the nervous system (NS) [12,13]. The
presence of three proteins with identical function in the NS would be
surprising. In fact, (i) the functions and/or (ii) the localization/
expression levels within the NS may differ between these UCPs. (i)
Function in NS has not yet been clearly determined for any UCP. Based
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originally proposed to participate in thermogenesis, e.g. by modulat-
ing pre- and post-synaptic events by axonal thermogenesis [7,14].
However, no reliable evidence has been found apart from the fact that
UCP4-mRNA expression is increased in neurons exposed to cold
temperatures [6,7]. Other hypotheses propose that these proteins
participate in the regulation of ROS production or calcium homeo-
stasis [15–18]. Both possibilities are currently debated ﬁercely [16,18–
20]. The early occurrence of UCP4 and UCP5 homologs in the simplest
multicellular organisms supports the speculation that they might be
involved in apoptosis in the mammalian brain [1,21–23]. Alternative-
ly, the proton gradient may be used for the translocation of FA
peroxides outside of mitochondria [24].
(ii) The function(s) of UCP4 and other NS-related UCPs will remain
elusive until the transport activity of these proteins and protein
expression patterns under physiological and pathological conditions
are elucidated. The reason for the scarce and controversial data on the
UCP2, UCP4 and UCP5 protein distributions may be the lack of reliable
speciﬁc antibodies (ABs), due to the highly hydrophobic nature of
proteins, high sequence homology between members of mitochon-
drial anion carrier family, and poor accessibility to protein localized on
the inner mitochondrial membrane. Most functional studies of UCPs
found in NS rely on mRNA determination (for review [4,25]).
However, UCP2 mRNA found in different organs failed to predict the
amount or even the presence of UCP2 protein: whereas UCP2 mRNA
was found ubiquitously, UCP2 protein could be only detected in
spleen, stomach, lung and white adipose tissue (WAT) [26].
Surprisingly, no UCP2 could be detected in brain and spinal cord
under physiological conditions [26]. The distribution of UCP4 mRNA
observed by various research groups is controversial. UCP4mRNAwas
found in different brain regions including fetal brain [1], spinal cord
[6], in peripheral nervous system and kidney [27]. UCP5 at mRNA level
has been detected in mouse brain, testis, WAT, kidney, brown adipose
tissue (BAT), skeletal muscle, liver, and heart [7]. UCP4 and UCP5 have
not been yet studied at protein level in detail.
The main goal of the present study was to elucidate the
distribution pattern of UCP4 protein under physiological conditions
and during development. For this, we designed two antibodies against
UCP4 and evaluated these using recombinant proteins, organs, tissue
extracts and cell cultures. The results are discussed in terms of UCP4's
possible functions.
2. Materials and methods
2.1. Cell cultures
2.1.1. Hippocampal rat neurons
With slight modiﬁcations, hippocampal neurons were prepared
and cultivated from embryonic days 18–19 (E18–E19) Wistar rats as
previously described [28]. Brieﬂy, dissociated cells were plated onto
poly-L-lysine-coated glass coverslips at a density of 50–100cells/
mm2. After 3 h in vitro, medium was changed to Neurobasal A
medium supplemented with 2% B27 (Gibco®Invitrogen Cell Culture,
Karlsruhe, Germany) and the antibiotics penicillin and streptomycin.
After 8–21 days in culture, the cells were processed by means of
immunoﬂuorescence or Western blotting.
2.1.2. Cortical neuron cultures from embryonic mice
Serum-free preparation of cortical primary cultures was per-
formed with E17 (±0.5 days) mouse embryos (C57BL/6) [29].
Embryonic cortices were mechanically dissociated in HBSS buffer
(without Ca2+ and Mg2+) with trypsin (0.25%) for 10 min at 37 °C.
Trypsination was stopped by adding minimum essential medium,
supplemented with 0.6% glucose, 10% horse serum (Gibco®Invitrogen
Cell Culture, Karlsruhe, Germany), and antibiotics penicillin and
streptomycin. Further mechanical dissociation was performed byadding additional DNAse I (0.06%). Cells were cultured on poly-L-
lysine-coated coverslips at a density of 75,000cells/cm2. After 3 h in
vitro, medium was changed to Neurobasal A medium supplemented
with 2% B27 (Gibco®Invitrogen Cell Culture, Karlsruhe, Germany),
0.5 mM glutamine, and the antibiotics penicillin and streptomycin.
After 8–21 days in culture, the cells were processed by means of
immunoﬂuorescence or Western blotting.
2.1.3. Astrocyte and microglia cultures from mouse
For astrocyte and microglia preparation, neocortex from mouse
pups aged P1–P3 was isolated [30]. The tissue was washed in DMEM
4.5 g/l glucose, containing 10% fetal bovine serum, 200 mMglutamine
(Invitrogen) and 100 U/ml penicillin/streptomycin. Following careful
homogenization with a ﬁre-polished Pasteur pipette und centrifuga-
tion at 300×g, 4 °C for 1 min the supernatant was transferred into a
new tube, homogenized again and centrifuged for 5 min at 1200×g,
4 °C. The pellet was resuspended in fresh medium and plated in
culture ﬂasks, which had been pre-coated with poly-L-lysine. The cells
were incubated at 37 °C with 5% CO2. After two days medium was
changed for fresh medium and the cells were allowed to continue
incubating until most of the microglia had detached from the
astrocytes. To remove the remaining microglia attached to the
astrocytes the cells were shaken for 2 h at 37 °C. Afterwards the
supernatant was plated again in culture medium containing 2% fetal
calf serum. The astrocytes still attached to the bottom of the culture
ﬂask were used for further experiments.
2.2. Production of recombinant uncoupling proteins
Cloning, expression and puriﬁcation of mouse UCP4-eGFP and
mouse UCP5 are described in the Supplementary material. Production
of recombinant mouse UCP1 was described previously [31–33].
Recombinant human UCP2 was donated by Dr. P. Jezek (Prague,
Czech Republic). Because the N-terminal peptide sequence of mouse
UCP2 has 100% homology to human UCP2, the latter was used in our
experiments for the evaluation of mouse UCP4 antibody. The
abbreviations UCP1, UCP2, UCP4 and UCP5 are used for both the
human and mouse proteins throughout the text.
2.3. Animals
Female C57BL/6 mice aged 1 day, 10 days, 30 days and 5 months
(12 mice of each age group) were purchased from the animal facility
of the Free University Berlin (Germany) and Charles River (Sulzfeld,
Germany). Animals were deeply anesthetized with a mixture
containing ketamine (Pﬁzer, Karlsruhe, Germany) and xylazine
(Rompun@, Bayer, HealthCare, Leverkusen, Germany), then transcar-
dially perfused with cold 0.1 M phosphate buffer saline (PBS). Brain,
spinal cord, thymus, heart, small intestine, testis, white adipose tissue,
skeletal muscles, lung, spleen, stomach, adrenal gland, liver, and
kidney were removed, frozen in liquid nitrogen and stored for further
Western blot analyses at−80 °C. For immunohistochemistry, tissues
were collected after perfusion with 4% paraformaldehyde (PFA).
2.4. Puriﬁcation of mitochondria from various mouse tissues
For preparation of pure mitochondria adult female mice (C57BL/
6J) were sacriﬁced by atlantoaxial dislocation. Brain, kidney and liver
were taken out immediately and immersed in ice-cold phosphate
buffered saline (PBS). During subsequent processing the tissues from
each single animal were kept separate, no pooling took place. Brain
and kidney were ﬁrst meshed with a pair of scissors. Then, after
addition of 1 ml isolation medium [84 ml medium A (0.1 M sucrose,
1 mM EDTA, 20 mM MOPS, pH 7.4 and 1 g/l BSA)+10 ml 100 mM
triethanolamine+1 ml 100 mM phenylmethylsulfonylﬂuoride
(PMSF)+5 g Percoll™+2 Complete™ tablets (Roche, Mannheim,
2311A. Smorodchenko et al. / Biochimica et Biophysica Acta 1788 (2009) 2309–2319Germany)+18.2 mΩMillipore water to a ﬁnal volume of 100 ml] the
cells were disrupted with 5 up- and down-strokes of a tightly ﬁtting
Potter–Elvehjem-homogenizer (Heidolph, Schwabach, Germany) atFig. 1. Design of antibodies to UCP4 and their validation. A. Putative structure of UCP4 based o
rabbit immunization is marked in red (UCP4-1) and black (UCP4-8). B. Comparison of mitoc
blast. The sequence of N-terminus peptide used for rabbit immunization ismarked in red. The
program. Signature sequence motif of the SLC25 family [46] is marked in bold. C. Evaluation
eGFP (63 kDa), but not recombinant UCP1, UCP2, UCP5. Recombinant UCP1, UCP2, and UCP5
Maximal 1 µg recombinant proteinwas loaded per lane. D. Co-localization of UCP4withmitoc
for UCP4 and visualized by confocal microscopy using Alexa 568 as secondary AB (red). Mit1000 rpm. The homogenate was centrifuged at 600×g for 10 min, and
the supernatant was collected. The liver tissue was disrupted after
addition of 2 ml of the isolation medium with an Ultraturax™n data for UCP1 [45] and hydrophobicity plot for UCP4. Localization of peptides used for
hondrial carriers with the highest homology to UCP4 (Slc25/27) in NCBI BLAST/protein
alignment of the N-Termini ofmitochondrial carriers was performed using the ClustalW
of the antibody against UCP4 in Western blot. Anti-UCP4 AB detects recombinant UCP4-
were detected by speciﬁc anti-UCP1, anti-UCP2, anti-UCP5 antibodies (AB), respectively.
hondria of rat neurons. Culture of rat primary hippocampal neuronswas immunostained
ochondria were counterstained with MitoTracker 633 (green). Scale bar, 20 µm.
2312 A. Smorodchenko et al. / Biochimica et Biophysica Acta 1788 (2009) 2309–2319(Heidolph) and centrifuged at 600×g for 10 min after which the
supernatant was collected. Subsequently the collected 600×g super-
natants were centrifuged at 10,000×g for 10 min and the pellet was
resuspended in washing buffer [0.25 M sucrose, 0.1 mM EDTA].
The crude mitochondrial preparation was loaded onto a continu-
ous gradient consisting of 8 ml of 30% (v/v) Percoll™ in washing
buffer and centrifuged continuously at 50,000×g for 90 min at 4 °C in
a Sorvall™ T1270 rotor. After centrifugation two separate rings hadFig. 2. Tissue expression of UCP4. A. Representative Western blot of total lysates from neuron
7-white adipose tissue, 8-testis and 9-adrenal gland) tissues of adult mice using anti-UCP4
each lane 50 µg protein was loaded. B. RepresentativeWestern blot of isolatedmitochondria
loading control. 10 µg mitochondrial protein was loaded per lane. C. CLSM of hepatic lobule
anti-UCP4 AB (green), anti-VDAC AB (red) and DAPI (blue). CV — central venule, H— hepato
(PT) from adult C57BL/6 mouse kidney. Vibratome sections (50 µm thick) were labeled with
by Alexa-568, red) and DAPI (blue). Scale bar 10 µm. E. CLSM images of peripheral ganglion
stomach were double-labeled using anti-UCP4 AB (green), anti-MAP2 AB (red) and DAPI (formed and the lower ring (themitochondrial fraction) was aspirated,
washed with washing buffer and centrifuged at 10,000×g for 10 min.
The pellets were stored at −80 °C.
2.5. Western blot analysis
Protein samples forWestern blotswere obtained frommouse tissue,
mitochondria and cell cultures. Tissue and mitochondria samples wereal (1-brain) and non-neuronal (2-spleen, 3-lung, 4-thymus, 5-heart, 6-skeletal muscle,
AB. Anti-GAPDH AB and anti-VDAC AB were used as control for the sample loading. For
lysates from liver (a), kidney (b) and brain (c) using anti-UCP4 AB and anti-VDAC AB as a
from adult C57BL/6 mouse liver. Vibratome sections (50 µm thick) were labeled with
cyte, S — sinusoids. Scale bar 10 µm. D. CLSM image of distal (DT) and proximal tubules
anti-UCP4 AB (visualized by secondary AB Alexa-488, green), anti-VDAC AB (visualized
cells in adult C57BL/6 mouse stomach (intermuscular plexus). Vibratome sections of
blue). Scale bar 5 µm.
2313A. Smorodchenko et al. / Biochimica et Biophysica Acta 1788 (2009) 2309–2319crushed in lysis buffer (20 mM Tris; 0.25 mM sucrose; 5 mM EDTA;
1 mMEGTA; pH7.5)with protease inhibitor cocktail (Sigma, Germany).
Cultured cellswerewashedwith ice-cold 0.9%NaCl and collected in lysis
buffer. After sonication (Bandolin Sonoplus GM70: 3×3 s, continuousFig. 3. Comparison of UCP4 expression in different brain regions. A–E. Representative photo
brain stem (B), frontal lobe of cortex (C) and transversal sections of spinal cord (E) from ad
UCP4 AB, ampliﬁed with ABC and visualized with DAB. PC — Purkinje cells, GC — granular
F. RepresentativeWestern blot of UCP4 distribution in different regions of the central nervous
were stained with anti-UCP4 AB, anti-NeuN AB, anti-NF-68 AB. Anti-β-actin and anti-VDAC
G. Quantiﬁcation of Western blot showing the relative distribution of UCP4 normalized to V
cerebellum (Ce), spinal cord (SC) in adult C57BL/6 mice (5 months old). The deviation of eac
in the experiment was set to 100%. Values are mean±SD for n=9 mice, ⁎Pb0.05.mode) lysate was incubated for 30 min on ice before centrifugation for
10 min at 2500 rpm. The supernatant was stored at−20 °C.
At least 10 µg protein was loaded on 15% SDS-Gel. Precision Plus
Protein Dual Color Standard (Bio Rad, Germany) was used as sizemicrographs demonstrating the UCP4 expression in coronal sections of cerebellum (A),
ult C57BL/6 mice. Vibratome sections were immunostained with afﬁnity-puriﬁed anti-
cells, MC — molecular cells, WM — white matter, VH — ventral horn. Scale bar, 50 µm.
system.Membranes loadedwith tissue from adult mice lysates (20 µg protein per lane)
ABs were used as a control for sample loading and mitochondrial number, respectively.
DAC in different regions of the central nervous system — cortex (Co), brain stem (BS),
h ratio from the mean ratio is given as percentage, whereby the mean ratio of all values
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2315A. Smorodchenko et al. / Biochimica et Biophysica Acta 1788 (2009) 2309–2319marker. After gel running, blotting was accomplished with nitrocellu-
lose membrane BA 85 (Schleicher&Schüll, Germany) using a Semi-Dry
Electro Blotter (PEQLAB, Germany) for 50 min at 14 V. Blocking was
performed for at least 1 h at room temperature (RT) in 1×TBS-buffer;
2% BSA; 0.05% Tween 20; 0.02% Thimerosal. The membranes were ﬁrst
incubated with afﬁnity puriﬁed antibody (AB) against mUCP4 (1:500)
overnight at 4 °C in the same buffer. After washing 3 times (1×TBS;
0.05% Tween 20) they were incubated with secondary horseradish
peroxidase conjugated AB (1:5000, anti-rabbit IgG; GE Healthcare, UK)
in block solution for 1 h at RT. After washing, the immunoreaction was
visualized using Pierce ECL Western Blotting Substrate on CL-Xposure
ﬁlms. For quantiﬁcation, VDAC and actinwere consecutively detected at
the samemembrane. After stripping in 100 mM sodium citrate solution
(pH 2.2) for 10 min at RT and washing, the procedure of immunodetec-
tion was repeated, starting with blocking. Anti-VDAC, anti-GAPDH or
anti-β-actin AB (Table S1, Supplementarymaterials)were incubated for
1 h at RT in blocking solution. Anti-mouse IgG (GE Healthcare, UK,
dilution 1:5000) served as secondary AB. Immunoblots were quantiﬁed
by densitometry using Image J (http://rsb.info.nih.gov/ij/).
2.6. Immunocytochemistry (ICC) and immunohistochemistry (IHC)
Primary neuronal cell cultures, grown on poly-L-lysine-coated
coverslips, were ﬁxed with cold 4% PFA for 20 min, washed in 0.1M
PBS, permeabilized with 0.2% Triton X-100 and incubated in 10% fetal
calf serum (Biochrom, Berlin, Germany) for 1 h at RT for blocking of
non-speciﬁc binding. Thereafter, cells were double-labeled with
appropriate primary AB (Table S1, Supplementary materials) over-
night at 4 °C. Negative control sections were incubated in a similar
manner, except that the primaryABwas replacedwith fetal calf serum.
For visualization of primary ABs, secondary ABs (Alexa-488-, Alexa-
568-, and Alexa-633-conjugated; Table S1, Supplementary materials)
in block solutionwere applied for 90 min at RT. After rinsing in PBS, the
coverslips were gently adhered to the objective glass with Immu-
Mount (ThermoElectron Corporation, Pittsburg, PA, USA) ormounting
medium with DAPI (Table S1, Supplementary materials).
For IHC, 50 µm thick sections of brain, spinal cord, liver and kidney
were cut with a vibratome (Microm HM-650V, Sigmann Elektronik,
Germany). To avoid endogenous peroxidase activity (light microscopy)
free-ﬂoating vibratome sections were ﬁrst incubated with 0.3% H2O2
(Sigma, Germany), then permeabilized and blocked with 0.5% Triton X-
100 and 10% normal goat serum (Vectashield, Vector Laboratories,
Burlingame, USA) for 60 min at RT. Subsequently, tissues were labeled
overnight at 4 °C with one (for light microscopy) or two (for confocal
microscopy) appropriate primary ABs (Table S1, Supplementary
materials). Control sections were incubated only in the presence of
normal goat serum and Triton X-100. The visualization of antigen–
antibody complexes was performed by both immunoﬂuorescence and
avidin–biotin-peroxidase complex (ABC) labeling. Biotinylated second-
ary anti-rabbit or anti-mouse IgG ABs were applied for 90 min at RT.
Then sections were incubated with ABC complex for 60 min and
developed in 3,3′-diaminobenzidine (DAB, Sigma-Aldrich, Germany).
After rinsing in PBS, tissues were mounted on slides, dehydrated
through a graded series of ethanol, cleared in xylene, and coverslipped
with Entellan@ (Merck, Darmstadt, Germany). For visualization of
primary ABs using confocal microscopy, secondary ABs (Alexa-488-,
Alexa-568-, and Alexa-633-conjugated; Table S1, SupplementaryFig. 4. Cellular and subcellular localization of UCP4 in neuronal cell cultures. A. Representativ
with cell lysates (20 µg protein per lane) were stained with anti-UCP4 AB and speciﬁc AB for
anti-VDAC ABs were used as a control for sample loading and mitochondrial number respec
was related to the housekeeping gene GAPDH. C. Representative 3D CLSM images from
localization of UCP4 (anti-UCP4 AB, green) with mitochondria (anti-VDAC AB, red). The sta
UCP4 is not present in all mitochondria in processes (circle). 3D reconstruction of images ta
10 µm. D. Poor UCP4 immunoreactivity (green) was detected in astrocytes (arrows) stained
DAPI. Scale bar 20 µm. E. Representative CLSM images from rat primary hippocampal neuro
(JC1, red). Scale bar 20 µm.materials) in block solution were applied for 90 min at RT. After rinsing
in PBS, tissue samples were coverslipped with Immu-Mount (Thermo
Electron Corporation, Pittsburg, PA, USA) or mounting medium with
DAPI (Table S1, Supplementary materials).
2.7. Light and confocal microscopy
Digital images of selected sections were taken using an Olympus
BX-51 microscope (Hamburg, Germany). Confocal images were
acquired with an upright laser microscope (Leica DM 2500) equipped
with a 63× objective (oil-immersion) using sequential scanning with
the 405 nm spectral line of a blue diode laser (for DAPI), the 488 nm
line of an argon-ion laser, the 543 nm and 633 nm lines from helium–
neon lasers (for Alexa-488, Alexa-568 and Alexa-633 respectively).
During the processing stage individual image channels were pseudo-
colored with red, green and blue corresponding (if not otherwise
indicated) to each of the ﬂuorophore emission spectral proﬁles. All
images were merged and compiled using Image J. Background
correction and adjustment of brightness and contrast were performed
in Image J, equivalent settings were used for control images. Three-
dimensional (3D) reconstitution was performed using the Volocity 4
Program (Improvision Ltd., Coventry, England).
3. Results
3.1. Design and validation of antibodies against mUCP4
Prior to production of speciﬁc ABs against mUCP4, two peptide
sequenceswere chosen based on their localization (Fig. 1A): KLLPLTQ-
RWPRTSK (on the N-terminus 8–21, UCP4-1) and MNQPRDKQGR-
GLLYKS (in the third matrix loop, 256–271, UCP4-8). These sequences
were compared with records in the NCBI protein bank to exclude
homology and later AB cross-reactivity with other mitochondrial
anion transporters, including UCP2 and UCP5, present in brain.
Sequence alignment of SLC25 family members was performed using
the ClustalW program (http://align.Genome.jp) and is shown in
Fig. 1B for the UCP4-1 peptide, used in our experiments later.
Comparison between mouse and rat UCP4 sequences reveals two
mismatches for UCP4-1 and 100% identity for UCP4-8 between both
species. UCP4 speciﬁc ABs were generated in rabbits against both
peptides and later afﬁnity puriﬁed on a peptide column (Pineda
Antibody Service, Berlin, Germany).
The speciﬁcity of ABs was examined by Western blot analysis,
immunocytochemistry (ICC) and immunohistochemistry (IHC).Western
blots were performed using recombinant uncoupling proteins (UCP4-
eGFP, UCP1, UCP2 and UCP5, Fig. 1C), extracts from mouse brain tissue
(Fig. S1, Supplementary material) and primary neuronal cultures (1D).
Comparison of ABs to both peptides after immunostaining of neurons
revealed that amino acids 8–21 (UCP4-1 peptide, Fig. 1D) were fully
accessible, whereas 256–271 (UCP4-8 peptide, data not shown) barely
accessible to the ABs in native mUCP4. As demonstrated inWestern blot
(Fig. 1C) anti-UCP4-1 AB at dilution 1:1000 correctly recognized both the
recombinant UCP4-eGFP (predicted MW 63 kDa) and UCP4 in brain
tissue extract (approximately MW 36 kDa, Fig. S1, Supplementary
material). Anti-UCP4-8 AB was unspeciﬁc (data not shown) and was
omitted from further analyses in this study. Recombinant UCP1, UCP2
and UCP5 were undetectable with the new anti-UCP4-1 AB (Fig. 1C, lefteWestern blot of UCP4 distribution in different mice neuronal cells. Membranes loaded
neurons (anti-Tuj-1), astrocytes (anti-GFAP) and microglia (anti-IBA). Anti-β-actin and
tively. B. Relative UCP4 gene expression in different mice neuronal cells. UCP4 amount
rat primary hippocampal neurons (stained with MAP2, blue), demonstrating the co-
ining patterns for UCP4 and VDAC overlap (yellow) mainly in the cell bodies. Notably,
ken at different z-levels was performed with Volocity Software (Improvision). Scale bar
with an antibody against GFAP (red). Blue signal indicates nuclear DNA labeled with
ns demonstrating the co-localization of UCP4 (anti-UCP4 AB, green) with mitochondria
2316 A. Smorodchenko et al. / Biochimica et Biophysica Acta 1788 (2009) 2309–2319side). In contrast, each of these recombinant proteins was detected by
antibodies speciﬁc for each protein (Fig. 1C, right side).
Using anti-UCP4-1 (referred to as anti-UCP4 in the text below) as
primary AB and Alexa-568-conjugated secondary AB we demonstrat-
ed the presence of UCP4 in rat hippocampal (Fig. 1D) and mouse
cortical (data not shown) primary neuronal cultures. To investigate
the subcellular localization of UCP4 we (i) double-stained neurons
with MitoTracker (Fig. 1D, green) and anti-UCP4 AB (Fig. 1D, red) and
(ii) evaluated UCP4 in isolated brain mitochondria (Fig. 2B) by
Western blotting. In both cases UCP4 was detected in mitochondria.
3.2. Assessment of the tissue-speciﬁc expression of mUCP4
Positively evaluated AB against mUCP4 was then used to study the
tissue distribution of mUCP4. We analyzed the presence of mUCP4 inFig. 5. Cellular localization of UCP4 in neuronal tissues. A. Light micrographs of dentate
(astrocyte marker), MAP2 (neuronal marker) and VDAC (mitochondrial marker) imm
immunoreactivity patterns. Scale bar, 50 µm. B. Representative CLSM images from hippocam
Top panel. Vibratome sections of cornu ammonis (CA1, 50 µm thick) were double-immunost
Scale bar, 30 µm. Middle panel. Double-staining of astrocytes in CA1 with antibodies agai
pyramidal cells in frontal cortical lobe with antibodies against MAP2 (red) and anti-UCP4 (different organs, previously described at mRNA level, using Western
blotting and IHC. Western blot analysis demonstrated the presence of
the protein in whole brain extract (Fig. 2A, lane 1) and no protein
bands corresponding to UCP4 in lysates from spleen, lung, thymus,
heart, muscles, white adipose tissue, testis, adrenal gland (Fig. 2A,
lanes 2–9), large intestine, stomach and small intestine (data not
shown) and in mitochondria from liver or kidney (Fig. 2B). Immu-
nohistochemical data supported these results. Fig. 2C shows liver
double-stained for the mitochondrial marker VDAC (visualized by
Alexa-568, red) and UCP4 (visualized by Alexa-488, green), revealing
the absence of UCP4 in mitochondria of this tissue. Because UCP4-
mRNA has been observed in kidney [27], we performed double-
immunoﬂuorescence staining of kidney from C57BL/6 mouse with
anti-UCP4 and anti-VDAC ABs. Anti-VDAC AB was used as a
mitochondrial marker. Our results showed that mitochondria ingyrus (DG) from hippocampal formation of adult C57Bl/6 mouse shows UCP4, GFAP
unoreactivity. In contrast to GFAP staining, UCP4, VDAC and MAP2 show similar
pal formation of adult C57Bl/6 mouse, demonstrating the cellular localization of UCP4.
ained with antibodies against the mitochondrial marker VDAC (red) and UCP4 (green).
nst GFAP (red) and UCP4 (green). Scale bar, 30 µm. Bottom panel. Double-staining of
green). Scale bar, 10 µm.
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red), but not UCP4-dependent signal (Fig. 2D).
To test for the presence of UCP4 in the peripheral nervous system
(PNS), we carried out the immunological staining of ganglia of
different organs including uterus, large intestine and stomach.
Confocal laser scanning microscopy revealed that cell bodies of
MAP2-positive neurons exhibited only weak immunoreactivity for
UCP4. Fig. 2E shows ganglion cells of intramuscular plexus of stomach
after staining with anti-MAP2 AB (visualizedwith Alexa-568, red) and
anti-UCP4 AB (visualized with Alexa-488, green).
3.3. Expression of UCP4 in different regions of the central nervous system
(CNS)
UCP4 expression in different CNS regions of adult mice (5 months
old) was assessed by immunohistochemistry (Fig. 3A–E) and Western
blot analysis (Fig. 3F–G) and compared with the distribution of UCP4
mRNA described earlier [1,6]. Our results conﬁrmed the presence of the
protein in all examined brain areas (cortex, brain stem, and cerebellum)
and spinal cord at different levels. The results of Western blot
quantiﬁcation showed that UCP4 expression is highest in the cortex of
adult mouse (Fig. 3G), followed by the cerebellum and is present at
similar levels in the brain stem and spinal cord. The UCP4 proteinFig. 6. Expression of UCP4 in brain and hippocampal neuronal cultures during developm
hippocampus show an increase in protein levels from embryonic (E14) to postnatal stages (P
the ratio of UCP4 to VDAC in different regions of the central nervous system— cortex, brain st
ratio is given as percentage, whereby the mean ratio of all values in the experiment was set t
hippocampal neurons of different ages (1, 7 and 21 days in culture) stained with afﬁnity-pamount was normalized to the amount of the mitochondrial marker
VDAC to relate the UCP4 concentration to the mitochondrial number,
which varied between different regions (Fig. S2, Supplementary
material). Analyzing the regional UCP4 distribution, we hypothesized
that the high UCP4 expression in cortex may reﬂect the high amount of
neurons (or neuronal cell bodies) in this region. To prove this idea we
stained the brain regions under study with NeuN (speciﬁc for neuronal
nuclei andperikarya) andNF (speciﬁc forneuronal axonsanddendrites).
Western blots (Fig. 3F) demonstrate that NeuN is predominantly
expressed in cortex and cerebellum. In contrast, the highest expression
of NF in the adult mice was detected in the spinal cord and brain stem,
which exhibited the lowest expression of UCP4 (Fig. 3F, S4, Supplemen-
tary materials). Immunohistochemical staining of spinal cord (Fig. S4,
Supplementarymaterials) shows that UCP4 is expressed predominantly
in greymatter, which is rich in neuronal cell bodies (visualized by NeuN
and MAP2) and poorly expressed in white matter, containing neuronal
processes (visualized by NF 68). The mitochondria, visualized by anti-
VDAC AB, are distributed equally between grey and white matter.
3.4. Cellular and subcellular localization of UCP4
UCP4 content in neurons, astrocytes and microglia cells was
evaluated at mRNA and protein levels. Fig. 4A and B show that bothent. A. Representative Western blots of UCP4 expression in murine neocortex and
30). 20 µg protein was loaded for each lane. B. Quantiﬁcation of Western blots showing
em, cerebellum, spinal cord— at various ages. The deviation of each ratio from themean
o 100%. Values for each region are mean±SD for n=9, ⁎Pb0.05. C. Cultured rat primary
uriﬁed UCP4 antibody. Scale bar, 20 µm.
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detected in microglia cells. To compare the protein expression in
neurons and astrocytes, we co-localized anti-UCP4 AB with neuron
(MAP2)- or astrocyte (GFAP)-speciﬁc markers in double-labeling
experiments. Representative confocal images show high expression of
UCP4 (Fig. 4C, green) in neurons (Fig. 4C, blue) and much lower
immunoreactivity in astrocytes (Fig. 4D, red) conﬁrming the ﬁndings
of other groups at mRNA and protein levels [6].
Immunohistochemical staining of brain tissue with ABs against
UCP4, MAP2, GFAP and VDAC revealed a similar expression pattern
between UCP4 and MAP2 and not between UCP4 and GFAP (Fig. 5A),
indirectly supporting our two observations: low expression of UCP4 in
astrocytes (Fig. 4A and B) and predominant protein expression in
neuronal cell body mitochondria (S4, Supplementary material).
Confocal microscopy of double-stained brain sections from adult
C57BL/6 mice with anti-UCP4 AB (visualized by Alexa-488, green)
and monoclonal ABs against VDAC, MAP2, GFAP (all visualized by
Alexa-568, red, Fig. 5B) conﬁrmed our ﬁndings.
To test our hypothesis that UCP4 is mainly expressed in
mitochondria of neuronal cell bodies, we double-immunostained a
primary neuronal culture with anti-UCP4 AB and AB against
mitochondrial protein VDAC (Fig. 4C) or with anti-UCP4 AB and
potential-sensitive dye JC1 (Fig. 4E). The co-localization of both
markers showed the preferential expression of UCP4 in mitochondria
of neuronal cell bodies and in single mitochondria of cell processes. To
exclude the artifacts resulting from different confocal levels we
performed 3D reconstruction of images taken at different z-levels
with Volocity Software (Improvision) (Fig. 4C).
3.5. Assessment of age-dependent expression of UCP4 under physiological
conditions
The variation in UCP4 expression during development may be
connected to its putative role in ROS regulation, proliferation,
differentiation or apoptosis. To determine whether UCP4 is develop-
mentally regulated, we examined brain tissues of fetal and adult mice,
and neuronal cell cultures at different ages (days in culture).
Western blot analysis of murine neocortex and hippocampus
(Fig. 6A) shows the presence of UCP4 protein as early as E14, followed
by protein level increase from embryonic to postnatal stages. The
presence of protein in the embryonic brain conﬁrmed the observation
that UCP4 mRNA is present in both fetal and adult brain tissues [1].
The comparison of protein expression in cortex, cerebellum, brain
stem and spinal cord of mice of different ages demonstrates that
amount of UCP4 increases until the adulthood (1, 10, and 30 days)
(Fig. S3, A, Supplementary material), obviously mirroring the rise in
mitochondria number shown by VDAC staining (Fig. S3, B, Supple-
mentary material). Toward 5 months old age it remains constant,
although the number of mitochondria is still slightly increasing. The
direct comparison of UCP4 expression to VDAC expression (Fig. 6B)
shows that UCP4 is down-regulated after birth in all mouse CNS
regions except the cortex, where the protein levels were nearly
constant.
The increase of the absolute amount of UCP is visualized in mouse
neuronal cultures immunostained with anti-UCP4 AB. Fig. 6C compares
1, 7 and 21 day-old neurons. Morphologically, young cells of 1 daywere
smaller, without long processes and with UCP4 predominantly
localized in the perinuclear area, obviously reﬂecting the localization
of mitochondria.
4. Discussion
Using the newly designed and positively evaluated anti-UCP4 AB
we demonstrated for the ﬁrst time that UCP4 is expressed at protein
level in different regions of brain and in spinal cord. This is in
agreement with the distribution of UCP4 mRNA described by severalresearch groups [1,6,7], but does not support the results of other
groups, which showed the expression of mammalian UCP4 mRNA in
kidney and omental adipose tissue [34,35]. Interestingly, high
expression levels of atypical UCP4 mRNA were observed in the liver
and kidney of Xenopus laevis [36]. The authors proposed that during
phylogenesis UCP4 disappears from the periphery and can be found
only in brain. This is in contrast to the distribution of UCP2 and UCP5,
which are also found in other organs (see Introduction).
The description of UCP4 mRNA distribution among different brain
regions in the literature is contradictory. Mao et al. showed the lowest
UCP4 mRNA levels in spinal cord, medulla, corpus callosum and
substantia nigra [1]. Using immunoblot analysis Liu et al. demon-
strated that UCP4 protein amount varies among brain regions. The
cortex and hypothalamus appeared to have a larger amount of the
protein, however no statistical analysis was performed [6]. Our
comparison of different CNS regions in adult mice revealed the
highest UCP4 level in cortex, followed by the cerebellum, brain stem
and spinal cord (Fig. 3G). In contrast, the highest levels of UCP2
transcripts have been reported in the spinal cord and medulla [1],
whereas UCP5 transcripts have not been found in spinal cord at all [7].
Using the most speciﬁc commercially available anti-UCP2 antibody to
date (Santa Cruz Biotechnology Inc, USA) we could not reveal the
presence of UCP2 in brain or spinal cord at protein level (data not
shown), supporting the data reported by Pecqueur et al. [26]. The
regional distribution of UCP4 in brain of adult mice with preference to
the cortex (Fig. 3F, G) is in accordance with its preferential expression
in neurons, demonstrated in this work in both brain sections and
primary neurons co-cultured with astrocytes. Much lower levels of
UCP4 found in astrocytes (Fig. 4A–B, D) and no UCP4 in microglia
(Fig. 4A–B) at protein and mRNA levels are in accordance with the
study of Liu et al. [6] and can be indicative for a speciﬁc neuronal
protein function.
The amount of UCP4 continuously increases until birth, remains
almost constant in adult mice if compared to β-actin, (Fig. 6A, Fig. S3
A, Supplementary material) or decreases if compared to the
mitochondrial number (UCP4/VDAC, Fig. 6B). Such a pattern seems
to contradict the hypothesized thermogenic function of UCP4 in at
least two ways. Firstly, compared with UCP1, which has been
conﬁrmed as generating heat in BAT, the expression of UCP4 occurs
much earlier than that of UCP1 in BAT of mice, where it appears
directly before birth [37]. Secondly, UCP4 content in adult mice
decays, which is not compatible with the constant demand for
thermoregulation.
Another proposed function for “novel” UCPs is their putative
participation in the regulation of ROS. The evaluation of this
hypothesis is difﬁcult based on only morphological data. Our data
showed a gradual increase of UCP4 in the late gestation period, which
may support its proposed regulatory function and reﬂect the
organism's ongoing preparation for birth. However, antioxidant
enzymes in the brain have been shown to increase steeply prior to
birth [38–40], probably due to a sudden increase of oxygen to the
organism [38]. Such expression behavior was not seen in our
experiments.
ROS in small concentrations are known to be chemical mediators
that act on signaling pathways to modulate, among others, growth
and differentiation [41]. Our present study reveals that UCP4 appears
in brain at E14 (embryonic day 14, Fig. 6A). This coincides with the
initiation of the neurogenesis, which occurs in rodent brain around
E12–E14 [42–44]. On the other hand, we demonstrated that the
amount of UCP4 in mitochondria (UCP4/VDAC ratio) decreased after
birth in all regions apart from the cortex (Fig. 6B). Together with the
preferential UCP4 expression in neurons this fact may indicate that
UCP4 has a speciﬁc function in development, e.g. neuronal cell
differentiation. Interestingly, when ectopically expressed in preadi-
pocytes, UCP4 promotes their proliferation and inhibits their
differentiation in adipocytes [35].
2319A. Smorodchenko et al. / Biochimica et Biophysica Acta 1788 (2009) 2309–2319Summarizing, we have demonstrated that the newly designed
afﬁnity puriﬁed anti-UCP4 AB to the peptide sequence localized on the
N-terminus is speciﬁc for UCP4, does not cross-react with other
available uncoupling proteins and is restricted to mitochondria. By
comparison of the UCP4 distribution with the distribution described
for UCP2 and UCP5 in the literature, several signiﬁcant differences
could be established. The highest level of UCP4 in adult mice was
found in cortex. The intracellular distribution and developmental
expression pattern under physiological conditions do not support the
thermoregulatory function of UCP4. Further research is required to
evaluate the participation of UCP4 in ROS regulation and neuronal
development, to delineate the UCP4 expression under pathological
conditions and to reveal the transport modalities of UCP4.
Acknowledgements
This work was supported by Deutsche Forschungsgemeinschaft
(Po-524/3-1 and Po-524/5-1 to EEP). I. Sarilova was funded by a
Humboldt University International Research Grants (2007, 2008). The
authors thank Jutta Schüler for the excellent technical assistance,
Nicola Brandt, Beate Geist and Thorsten Trimbuch for the valuable
technical advice, J. A. Liebkowsky for the editorial assistance.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
References
[1] W.Mao, X.X. Yu, A. Zhong,W. Li, J. Brush, S.W. Sherwood, S.H. Adams, G. Pan, UCP4,
a novel brain-speciﬁc mitochondrial protein that reduces membrane potential in
mammalian cells, FEBS Lett. 443 (1999) 326–330.
[2] D.G. Nicholls, E. Rial, A history of the ﬁrst uncoupling protein, UCP1, J. Bioenerg.
Biomembranes 31 (1999) 399–406.
[3] V. Golozoubova, E. Hohtola, A. Matthias, A. Jacobsson, B. Cannon, J. Nedergaard,
Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold, FASEB J.
15 (2001) 2048–2050.
[4] Z.B. Andrews, S. Diano, T.L. Horvath, Mitochondrial uncoupling proteins in the cns:
in support of function and survival, Nat. Rev., Neurosci. 6 (2005) 829–840.
[5] J.S. Kim-Han, S.A. Reichert, K.L. Quick, L.L. Dugan, BMCP1: a mitochondrial
uncoupling protein in neurons which regulates mitochondrial function and
oxidant production, J. Neurochem. 79 (2001) 658–668.
[6] D. Liu, S.L. Chan, N.C. Souza-Pinto, J.R. Slevin, R.P.Wersto, M. Zhan, K. Mustafa, R. de
Cabo, M.P. Mattson, Mitochondrial UCP4 mediates an adaptive shift in energy
metabolism and increases the resistance of neurons to metabolic and oxidative
stress, Neuromol. Med. 8 (2006) 389–414.
[7] X.X. Yu, W. Mao, A. Zhong, P. Schow, J. Brush, S.W. Sherwood, S.H. Adams, G. Pan,
Characterization of novel UCP5/BMCP1 isoforms and differential regulation of
UCP4 and UCP5 expression through dietary or temperature manipulation, FASEB J.
14 (2000) 1611–1618.
[8] A.Y. Andreyev, T.O. Bondareva, V.I. Dedukhova, E.N. Mokhova, V.P. Skulachev, L.M.
Tsoﬁna, N.I. Volkov, T.V. Vygodina, The ATP/ADP-antiporter is involved in the
uncoupling effect of fatty acids on mitochondria, Eur. J. Biochem. 182 (1989)
585–592.
[9] X.X. Yu, D.A. Lewin, A. Zhong, J. Brush, P.W. Schow, S.W. Sherwood, G. Pan, S.H.
Adams, Overexpression of the human 2-oxoglutarate carrier lowers mitochondrial
membrane potential in HEK-293 cells: contrast with the unique cold-induced
mitochondrial carrier CGI-69, Biochem. J. 353 (2001) 369–375.
[10] J. Borecky, I.G. Maia, P. Arruda, Mitochondrial uncoupling proteins in mammals
and plants, Biosci. Rep. 21 (2001) 201–212.
[11] P. Jezek, E. Urbankova, Speciﬁc sequence of motifs of mitochondrial uncoupling
proteins, IUBMB Life 49 (2000) 63–70.
[12] D. Richard, S. Clavel, Q. Huang, D. Sanchis, D. Ricquier, Uncoupling protein 2 in the
brain: distribution and function, Biochem. Soc. Trans. 29 (2001) 812–817.
[13] D. Sanchis, C. Fleury, N. Chomiki, M. Goubern, Q. Huang, M. Neverova, F. Gregoire, J.
Easlick, S. Raimbault, C. Levi-Meyrueis, B. Miroux, S. Collins, M. Seldin, D. Richard,
C. Warden, F. Bouillaud, D. Ricquier, BMCP1, a novel mitochondrial carrier with
high expression in the central nervous system of humans and rodents, and
respiration uncoupling activity in recombinant yeast, J. Biol. Chem. 273 (1998)
34611–34615.
[14] T.L. Horvath, C.H. Warden, M. Hajos, A. Lombardi, F. Goglia, S. Diano, Brain
uncoupling protein 2: uncoupled neuronal mitochondria predict thermal
synapses in homeostatic centers, J. Neurosci. 19 (1999) 10417–10427.
[15] V.P. Skulachev, Uncoupling: new approaches to an old problem of bioenergetics,
Biochim. Biophys. Acta 1363 (1998) 100–124.
the online version, at doi:10.1016/j.bbamem.2009.07.018.[16] M. Trenker, R. Malli, I. Fertschai, S. Levak-Frank, W.F. Graier, Uncoupling proteins 2
and 3 are fundamental for mitochondrial Ca2+ uniport, Nat. Cell Biol 9 (2007)
445–452.
[17] S.L. Chan, D. Liu, G.A. Kyriazis, P. Bagsiyao, X. Ouyang, M.P. Mattson, Mitochondrial
uncoupling protein-4 regulates calcium homeostasis and sensitivity to store
depletion-induced apoptosis in neural cells, J. Biol. Chem. 281 (2006) 37391–37403.
[18] J. Nedergaard, B. Cannon, The ‘novel’ ‘uncoupling’ proteins UCP2 and UCP3: what do
they really do? Pros and cons for suggested functions, Exp. Physiol. 88 (2003) 65–84.
[19] P.S. Brookes, N. Parker, J.A. Buckingham, A. Vidal-Puig, A.P. Halestrap, T.E. Gunter,
D.G. Nicholls, P. Bernardi, J.J. Lemasters, M.D. Brand, UCPs — unlikely calcium
porters, Nat. Cell Biol. 10 (2008) 1235–1237.
[20] Z. Wu, J. Zhang, B. Zhao, Superoxide anion regulates the mitochondrial free Ca2+
through uncoupling proteins. Antioxid Redox Signal (in press).
[21] P. Hanak, P. Jezek, Mitochondrial uncoupling proteins and phylogenesis— UCP4 as
the ancestral uncoupling protein, FEBS Lett. 495 (2001) 137–141.
[22] M.P. Mattson, D. Liu, Mitochondrial potassium channels and uncoupling proteins
in synaptic plasticity and neuronal cell death, Biochem. Biophys. Res. Commun.
304 (2003) 539–549.
[23] P.W. Ho, D.Y. Chan, K.H. Kwok, A.C. Chu, J.W. Ho, M.H. Kung, D.B. Ramsden, S.L. Ho,
Methyl-4-phenylpyridinium ion modulates expression of mitochondrial uncou-
pling proteins 2, 4, and 5 in catecholaminergic (SK-N-SH) cells, J. Neurosci. Res. 81
(2005) 261–268.
[24] F. Goglia, V.P. Skulachev, A function for novel uncoupling proteins: antioxidant
defense of mitochondrial matrix by translocating fatty acid peroxides from the
inner to the outer membrane leaﬂet, FASEB J. 17 (2003) 1585–1591.
[25] S.Krauss, C.Y. Zhang, B.B. Lowell, Themitochondrialuncoupling-proteinhomologues,
Nat. Rev., Mol. Cell Biol. 6 (2005) 248–261.
[26] C. Pecqueur, M.C. Alves-Guerra, C. Gelly, C. Levi-Meyrueis, E. Couplan, S. Collins, D.
Ricquier, F. Bouillaud, B. Miroux, Uncoupling protein 2, in vivo distribution,
induction upon oxidative stress, and evidence for translational regulation, J. Biol.
Chem. 276 (2001) 8705–8712.
[27] T. Kitahara, H.S. Li-Korotky, C.D. Balaban, Regulation of mitochondrial uncoupling
proteins in mouse inner ear ganglion cells in response to systemic kanamycin
challenge, Neuroscience 135 (2005) 639–653.
[28] N. Brandt, K. Franke, M.R. Rasin, J. Baumgart, J. Vogt, S. Khrulev, B. Hassel, E.E. Pohl,
N. Sestan, R. Nitsch, S. Schumacher, The neural EGF family member CALEB/NGC
mediates dendritic tree and spine complexity, EMBO J. 26 (2007) 2371–2386.
[29] G.J. Brewer, J.R. Torricelli, E.K. Evege, P.J. Price, Optimized survival of hippocampal
neurons in B27-supplemented Neurobasal, a new serum-free medium combina-
tion, J. Neurosci. Res. 35 (1993) 567–576.
[30] N.E. Savaskan, L. Rocha, M.R. Kotter, A. Baer, G. Lubec, L.A. van Meeteren, Y. Kishi, J.
Aoki, W.H. Moolenaar, R. Nitsch, A.U. Brauer, Autotaxin (NPP-2) in the brain: cell
type-speciﬁc expression and regulation during development and after neuro-
trauma, Cell Mol. Life Sci. 64 (2007) 230–243.
[31] E. Urbankova, A. Voltchenko, P. Pohl, P. Jezek, E.E. Pohl, Transport kinetics of
uncoupling proteins: analysis of UCP1 reconstituted in planar lipid bilayers, J. Biol.
Chem. 278 (2003) 32497–32500.
[32] V. Beck, M. Jaburek, T. Demina, A. Rupprecht, R.K. Porter, P. Jezek, E.E. Pohl,
Polyunsaturated fatty acids activate human uncoupling proteins 1 and 2 in planar
lipid bilayers, FASEB J. 21 (2007) 1137–1144.
[33] V. Beck, M. Jaburek, E.P. Breen, R.K. Porter, P. Jezek, E.E. Pohl, A new automated
technique for the reconstitution of hydrophobic proteins into planar bilayer
membranes. Studies of human recombinant uncoupling protein 1, Biochim. Biophys.
Acta 1757 (2006) 474–479.
[34] T. Kitahara, H.S. Li, C.D. Balaban, Localization of the mitochondrial uncoupling
protein family in the rat inner ear, Hear. Res. 196 (2004) 39–48.
[35] M. Zhang, B. Wang, Y.H. Ni, F. Liu, L. Fei, X.Q. Pan, M. Guo, R.H. Chen, X.R. Guo,
Overexpression of uncoupling protein 4 promotes proliferation and inhibits
apoptosis and differentiation of preadipocytes, Life Sci. 79 (2006) 1428–1435.
[36] P.A. Keller, L. Lehr, J.P. Giacobino, Y. Charnay, F. Assimacopoulos-Jeannet, N.
Giovannini, Cloning, ontogenesis and localization of an atypical uncoupling
protein 4 in Xenopus laevis, Physiol. Genomics 22 (2005) 339–345.
[37] J. Houstek, J. Kopecky, Z. Rychter, T. Soukup, Uncoupling protein in embryonic
brown adipose tissue — existence of nonthermogenic and thermogenic mito-
chondria, Biochim. Biophys. Acta 935 (1988) 19–25.
[38] G.M. Rickett, F.J. Kelly, Developmental expression of antioxidant enzymes in
guinea pig lung and liver, Development 108 (1990) 331–336.
[39] I. Mavelli, A. Rigo, R. Federico, M.R. Ciriolo, G. Rotilio, Superoxide dismutase,
glutathione peroxidase and catalase in developing rat brain, Biochem. J. 204 (1982)
535–540.
[40] J.B. de Haan, M.J. Tymms, F. Cristiano, I. Kola, Expression of copper/zinc superoxide
dismutase and glutathione peroxidase in organs of developing mouse embryos,
fetuses, and neonates, Pediatr. Res. 35 (1994) 188–196.
[41] H. Sauer, M. Wartenberg, J. Hescheler, Reactive oxygen species as intracellular
messengers during cell growth and differentiation, Cell. Physiol. Biochem. 11 (2001)
173–186.
[42] X. Qian, Q. Shen, S.K. Goderie, W. He, A. Capela, A.A. Davis, S. Temple, Timing of CNS
cell generation: a programmed sequence of neuron and glial cell production from
isolated murine cortical stem cells, Neuron 28 (2000) 69–80.
[43] S. Temple, The development of neural stem cells, Nature 414 (2001) 112–117.
[44] C.M. Sauvageot, C.D. Stiles, Molecular mechanisms controlling cortical gliogenesis,
Curr. Opin. Neurobiol. 12 (2002) 244–249.
[45] M. Klingenberg, S.G. Huang, Structure and function of the uncoupling protein from
brown adipose tissue, Biochim. Biophys. Acta 1415 (1999) 271–296.
[46] F. Palmieri, The mitochondrial transporter family (SLC25): physiological and
pathological implications, Pﬂugers Arch. 447 (2004) 689–709.
